LEX-WK-MEGEN4ECcrawled 2021-10-27 09:38Z
FDA Releases Guidance on Resuming Normal Drug and Biologics Manufacturing Operations During COVID-19
Thomas Cosgrove · Global Policy Watch · Published September 17, 2020
Work details
- author
- Thomas Cosgrove
- firm or organization
- Covington & Burling LLP
- publication
- Global Policy Watch
- practice area
- Health Care and Life Sciences
- published
- 2020-09-17
Citation
Thomas Cosgrove, FDA Releases Guidance on Resuming Normal Drug and Biologics Manufacturing Operations During COVID-19, Global Policy Watch (September 17, 2020) [The Library at LexBlog, LEX-WK-MEGEN4EC, lexpid.org/MEGEN4EC]